These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8213491)

  • 21. Psychological and ethical considerations in screening for disease.
    Quaid KA
    Am J Cardiol; 1993 Sep; 72(10):64D-67D. PubMed ID: 8213500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolemia--screening to facilitate early prevention.
    Parhofer KG
    Dtsch Arztebl Int; 2014 Aug; 111(31-32):521-2. PubMed ID: 25145509
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.
    Goldman L; Goldman PA; Williams LW; Weinstein MC
    Am J Cardiol; 1993 Sep; 72(10):75D-79D. PubMed ID: 8213502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.
    Lázaro P; Pérez de Isla L; Watts GF; Alonso R; Norman R; Muñiz O; Fuentes F; Mata N; López-Miranda J; González-Juanatey JR; Díaz-Díaz JL; Blasco AJ; Mata P
    J Clin Lipidol; 2017; 11(1):260-271. PubMed ID: 28391894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes.
    Bhatnagar D
    Ann Clin Biochem; 2006 Nov; 43(Pt 6):441-56. PubMed ID: 17132275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying familial hypercholesterolemia in acute coronary syndrome.
    Gencer B; Nanchen D
    Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association.
    Wray R; Neil H; Rees J
    J R Coll Physicians Lond; 1996; 30(2):115-8. PubMed ID: 8709055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
    Turgeon RD; Barry AR; Pearson GJ
    Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The detection of heterozygous familial hypercholesterolemia in Ireland.
    O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C
    Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case-finding for familial hypercholesterolemia in the Asia-Pacific region.
    Hamilton-Craig I
    Semin Vasc Med; 2004 Feb; 4(1):87-92. PubMed ID: 15199437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.
    Stacpoole PW; Grundy SM; Swift LL; Greene HL; Slonim AE; Burr IM
    J Clin Invest; 1981 Nov; 68(5):1166-71. PubMed ID: 7298845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents.
    Kwiterovich PO
    Am J Cardiol; 1993 Sep; 72(10):30D-37D. PubMed ID: 8213494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of familial hypercholesterolemia in Taiwan: report of eleven cases.
    Chung MH; Chen KW; Chen JF; Lu WT; Sun JH; Lin JD
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):460-7. PubMed ID: 10584419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for familial hypercholesterolaemia.
    Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.